On Friday, in a somewhat ambiguous news release, Tekmira updated investors on the Phase II ebola stu... Read More
In a transformational deal announced earlier this week, Tekmira Pharmaceuticals (TSX:TKM, Nasdaq:TKM... Read More
It was a wild year for Life Sciences stocks on the TSX, with exciting new entrants and several stock... Read More
Shares of Burnaby-based Tekmira (TSX:TKM, NASDAQ:TKMR) are up today after the company late yesterday... Read More
Shares of Tekmira (TSX:TKM, Nasdaq:TKMR) are soaring in after market trading after news broke of the... Read More
After being halted today at the market close, Tekmira (TSX:TKM) announced that the FDA had verbally ... Read More
Tekmira (TSX:TKM, Nasdaq:TKMR) has always had a compelling story -the company is a pioneer in a exci... Read More
Yesterday, Tekmira (TSX:TKM) announced that it had settled the ongoing litigiation between it and Al... Read More
On Tuesday, Tekmira (TSX:TKM) announced that the temporary stop-work order announced on August 6th, ... Read More
Last week, Alnylam Pharmaceuticals (NASDAQ:ALNY) announced that it reported positive results from a ... Read More
On Tuesday, Tekmira (TSX:TKM) reported its Q1, 2012 results. Revenue of $3.6-million was a dip from ... Read More
There are many people who believe Canadian technology stocks are undervalued. Of course, as John May... Read More
In January, we looked back at the Canadian tech stocks that had an exceptional 2010, capped off by t... Read More
It’s been nearly a century since Canada’s greatest achievement in biotech took place; th... Read More